Ascendis Pharma A/S Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-12-20: Form 6-K; Period of report 2023-12-20; Description 6-K; Document d644871d6k.htm.
- 2023-12-19: Form 6-K; Period of report 2023-12-19; Description 6-K; Document d68011d6k.htm.
- 2023-12-13: Form 6-K; Period of report 2023-12-13; Description 6-K; Document d648648d6k.htm.
- 2023-12-11: Form 6-K; Period of report 2023-12-11; Description 6-K; Document d911705d6k.htm.